| (Values in U.S. Thousands) | Dec, 2022 | Dec, 2021 | Dec, 2020 | Dec, 2019 | Dec, 2018 |
| Sales | 6,380 | 2,110 | 2,950 | 3,050 | 5,790 |
| Sales Growth | +202.37% | -28.47% | -3.28% | -47.32% | +280.92% |
| Net Income | -43,430 | -35,070 | -26,050 | -20,020 | -15,730 |
| Net Income Growth | -23.84% | -34.63% | -30.12% | -27.27% | -32.85% |
Nighthawk Biosciences Inc
(NHWK)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
NightHawk Biosciences Inc. is a fully integrated biopharmaceutical company focused on the development of new drugs from discovery through commercialization. NightHawk Biosciences Inc., formerly known as Heat Biologics Inc., is based in DURHAM, N.C.
Fiscal Year End Date: 12/31